The evolution of assays for immuno-oncology research
Drug Discovery World
FEBRUARY 15, 2023
Genetically modified T cells stimulated with IL2 are now administered as cell therapy for multiple cancer cell types with beneficial results 3,4. Over 250 clinical trials are currently in progress, and novel immuno-oncological treatments are already proving to be successful. This continues to be the standard of care.
Let's personalize your content